Behnam Asgharian is a Gastroenterology physician. OpenAlex indexes 5 publications with 571 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 Dennis Dr
Sanford, NC 273306343
Telephone
919-774-4511Registry record last updated 16 Jan 2018.
Industry payments
36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202517 payments
- Janssen Biotech, Inc.Program year20255 payments
- Regeneron Healthcare Solutions, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
75.7%Proton pump inhibitor40%Pantoprazole Sodium74%Omeprazole19%Lansoprazole4%Rabeprazole Sodium4%Part D<11 patientsGuanylate Cyclase-C Agonist13.7%Linzess100%Part D≥40 patients+ 8 more classes in this area
Blood & clotting
7.4%Solutions for parenteral nutrition7.4%Peg 3350-Electrolyte100%Part D≥54 patientsAnti-infectives
6.6%Tetracycline-class Drug2.6%Doxycycline Hyclate100%Part D≥18 patientsNitroimidazole Antimicrobial2.6%Metronidazole100%Part D≥18 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1
The Journal of Clinical Endocrinology & Metabolism
2004 - Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1
Clinical Cancer Research
2004 - Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1
The Journal of Clinical Endocrinology & Metabolism
2003 - Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas
Alimentary Pharmacology & Therapeutics
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”